Getting semaglutide blood tests before starting treatment gives you and your prescriber a snapshot to compare against once the medication is running. Without that starting point, a lab value that looks odd three months in is hard to interpret, because nobody knows what was normal for you at the beginning. This post focuses on reading those results, understanding the kidney and hydration logic behind them, and keeping your data organized over time.
Semaglutide baseline labs can look confusing on paper. Here is how to read the main tests, understand the kidney and hydration logic, and organize your results before your appointment.
Why a baseline matters
A pre-treatment panel is a reference point. Once you start an injection, your numbers can shift for many reasons, and a baseline lets you separate medication effects from everything else going on in your life.
The reason you are starting shapes which tests make sense. Someone beginning for type 2 diabetes is usually already being monitored for glucose control, while someone starting for weight management may have different priorities. The prescribing information for Ozempic and Wegovy is not identical, so the panel your clinic chooses can reasonably differ.
Before you bring any printout to a visit, read the current prescribing information on Drugs@FDA. Pay close attention to the sections on acute kidney injury, dehydration, and diabetic retinopathy. The ADA Standards of Care also explain when to check kidney and metabolic markers in people taking GLP-1 receptor agonists, and that section is worth reading too.
Track the estimated level of each dose and know the right time to inject.
See it in the app
